The Hallmarks of Cancer
Cancer is many diseases with shared biology
"Cancer" is dozens of different diseases — breast, colon, prostate, lung, pancreatic — all with different biology and treatment. But they share a set of core features that explain why they behave the way they do. Understanding those features clarifies both risk and prevention.
Hanahan & Weinberg's 8 hallmarks
In 2011 Hanahan & Weinberg updated their classic Hallmarks of Cancer framework. Cancer cells: (1) sustain growth signalling, (2) evade growth suppressors, (3) resist cell death, (4) enable replicative immortality, (5) induce angiogenesis, (6) activate invasion + metastasis, (7) reprogram energy metabolism, (8) evade immune destruction.
Match hallmark to prevention lever
Connect each hallmark to the lifestyle factor most tightly tied to preventing it.
Mutation is necessary but not sufficient
Every person accumulates thousands of somatic mutations in their tissues over a lifetime — most do nothing. Cancer requires mutations to hit specific driver genes (TP53, KRAS, BRCA, etc.) AND for the surrounding tissue environment to permit them to proliferate. Lifestyle shapes that environment far more than mutation rate.
Counter-intuitive: most healthy tissue is full of "cancer" mutations
Sequencing studies of normal sun-exposed skin, esophagus, and colon find that **>25% of cells in middle-aged adults already carry classic cancer-driver mutations** — including activating KRAS, NOTCH1, and PIK3CA hits. They don't progress to tumours. The Hanahan & Weinberg framework's revision in 2022 added two **enabling characteristics** (genomic instability, tumour-promoting inflammation) precisely because mutation alone clearly isn't enough. The body's surveillance and tissue context block most rogue clones from ever becoming clinically detectable cancer.
The metabolism hallmark — Warburg revisited
In 1924 Otto Warburg observed that cancer cells **prefer fermentation to oxidative phosphorylation even when oxygen is plenty**. They burn glucose inefficiently to lactate (~2 ATP per glucose) instead of through mitochondria (~32 ATP). Modern view: this isn't a defect — it's an *adaptation*. The intermediates of glycolysis (ribose-5-phosphate, NADPH, glycerol) are the building blocks for replicating DNA, membranes, and cytosol. Tumours grow on biomass, not energy.
Why immunotherapy redrew the map
For 50 years cancer treatment was "poison every fast-dividing cell harder than the patient." In 2011 ipilimumab and in 2014 pembrolizumab proved that **releasing the brakes on T-cells** (PD-1 / CTLA-4 checkpoint inhibition) lets the immune system finish the job. Immune evasion was confirmed as a real, addressable hallmark. Long-tail responders — patients with metastatic melanoma alive 10+ years post-treatment — would have been called miracles in 2010.
Decade tipping points
Order these cancer-prevention findings from earliest to most recent.
Key Takeaway
Cancer is not 'random bad luck' for most people. Even healthy tissue is riddled with driver mutations that the body normally suppresses through metabolic, immune, and tissue-environment defences. The 8 (now 14) hallmarks map onto modifiable lifestyle factors. Prevention isn't avoiding every carcinogen — it's keeping your tissues a hostile place for any rogue clone that tries to scale.
References
- Hanahan & Weinberg — Hallmarks of Cancer: the Next Generation
- Somatic mutations in normal tissues — recent evidence
- Driver mutations in normal esophagus — somatic clonal expansion
- Hallmarks of Cancer — New Dimensions (2022 update)
- Understanding the Warburg effect — biosynthesis driver
- Pembrolizumab in advanced melanoma — KEYNOTE-006